Contrary to what many might expect, people using popular weight-loss medications like Ozempic and Wegovy are actually spending more on high-end chocolate, defying earlier predictions about a decline in sweets consumption. This surprising trend comes from a new report, which indicates that premium chocolate sales are climbing faster among GLP-1 users than in the general population.
According to Fox News, Swiss chocolatier Lindt & Sprüngli recently shared data from an internal study that directly counters the idea that GLP-1 drugs would dampen people’s interest in sweets. It seems that while consumers on these medications might be cutting back on calorie-dense foods like pasta and pizza, they’re still very much in the market for a little indulgence.
